Filter posts

Targacept reports positive Phase 2b trial results for depression treatment

Targacept, Inc. (NASDAQ: TRGT) presented data from its Phase 2b clinical trial of TC-5214 as …

Q&A with ExonHit Therapeutics’ Loïc Maurel, MD

We recently spoke with Loïc Maurel, M.D., president of ExonHit Therapeutics’ Management Board, one of …

Inovio begins HIV clinical trial of DNA vaccine

Inovio Biomedical Corporation (NYSE Amex: INO) and the HIV Vaccine Trials Network (HVTN) initiated a …

Methylgene to receive equity investment from Otsuka Pharmaceutical

MethylGene Inc. (TSX: MYG) agreed to issue 3,686,182 common shares to Otsuka Pharmaceutical Co., Ltd. …

Provectus starts compassionate use program for PV-10

Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) expanded its compassionate use program for PV-10, making the agent, …

Positive Palifosfamide Sarcoma Phase II Data from ZIOPHARM

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced positive data from the multicenter randomized Phase II trial …

Positive clinical trial results for Epeius

Epeius Biotechnologies Corporation announced results of its Rexin-G®  clinical trials. Administered as stand-alone therapy in …

Locus Pharmaceuticals and Novartis enter into research collaboration

Locus Pharmaceuticals has entered into a discovery research collaboration with Novartis. Locus will collaborate with …

UsiRNA reduces tumor growth in vivo

MDRNA, Inc. (NASDAQ: MRNA) presented new in vivo data showing continued progress in the advancement …

Medicago awarded U.S. Army contract

Medicago Inc. (TSX-V: MDG) has been awarded a proof of concept contract by the U.S. …